What is a characteristic of Hurthle cell (HCC) thyroid carcinoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Characteristics of Hürthle Cell Thyroid Carcinoma

Hürthle cell thyroid carcinoma often metastasizes to the cervical lymph nodes, making this its most distinctive characteristic among the options presented.

Clinical and Pathological Features

Hürthle cell carcinoma (HCC) is a rare and distinctive form of differentiated thyroid cancer, representing approximately 3-4% of all thyroid carcinomas 1. The World Health Organization (WHO) now recognizes HCC as a separate entity from follicular thyroid carcinoma due to its unique clinical, biological, and genetic features 2.

Key Characteristics:

  • Lymph Node Metastasis: HCC often metastasizes to cervical lymph nodes, particularly in cases with aggressive features 2, 1. This tendency for lymphatic spread is a hallmark feature that distinguishes it from conventional follicular thyroid carcinomas.

  • Bilaterality: HCC can frequently be bilateral or multifocal within the thyroid gland 3, contrary to option B which incorrectly states it is "seldom bilateral."

  • Surgical Management: Total thyroidectomy alone is often not sufficient treatment for HCC, especially for high-risk tumors 3, 4. This contradicts option A which suggests adequate treatment with total thyroidectomy only.

  • Radiation Exposure: HCC has been associated with previous neck radiation in some cases 2, making option D incorrect.

Risk Stratification and Prognosis

According to ESMO guidelines, HCC with extensive vascular and/or capsular invasion should be classified as high-risk, with an estimated recurrence risk of >20% 2. The AMES risk stratification system (age, distant metastasis, capsular extent, tumor size) is useful in predicting recurrence and mortality 4.

Prognostic Factors:

  • Tumor size >4 cm
  • Extrathyroidal extension
  • Vascular invasion
  • Presence of distant metastases
  • Extent of disease at operation (strongest predictor of recurrence)

Treatment Considerations

The appropriate surgical approach depends on risk factors:

  • Low-risk disease: Thyroid lobectomy may be sufficient for small, unifocal, intrathyroidal carcinomas 1
  • High-risk disease: Total thyroidectomy with central neck dissection is recommended, particularly for:
    • Tumors >4 cm
    • Presence of extrathyroidal extension
    • Clinically apparent lymph node metastases
    • Bilateral or multifocal disease

The effectiveness of radioactive iodine therapy remains controversial, as HCC generally produces thyroglobulin but rarely takes up radioactive iodine 3, 5.

Molecular and Pathological Characteristics

HCC is characterized by:

  • Large cells with abundant eosinophilic, granular cytoplasm
  • Hyperchromatic nuclei with prominent nucleoli
  • Numerous mitochondria with packed stacking cristae
  • Distinct molecular profiles compared to conventional follicular carcinomas 2, 1

Clinical Implications

The tendency for HCC to metastasize to cervical lymph nodes has important implications for surgical planning and follow-up. Careful evaluation of the cervical lymph nodes should be performed preoperatively, and therapeutic neck dissection should be considered for clinically apparent nodal disease 2, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.